Kevin Gao

Ph.D candidate in Molecular Pharmacology and Experimental Therapeutics at #MayoClinic. Sudden death genomics I Cardiac channelopathies

[Michael J. Ackerman MD,PhD @MJAckermanMDPhD]

In the life of a mentor, this past wk was unforgettable. 3 of my PhD students: ⁦@XGaoKevin⁩ ⁦@GarmanyRamin⁩ & ⁦@sahejbains⁩ successfully defended their PhD thesis. I started as their adviser, grew into their mentor, and became their “father”. So PROUD of them!

[Michael J. Ackerman MD,PhD @MJAckermanMDPhD]

I got to start my week ⁦@MayoClinic⁩ ⁦@MayoGradSchool⁩ w/ a truly special “Team Ackerman” event. ⁦@XGaoKevin⁩ successfully defended his PhD today & soon will be recognized as Dr. Gao. So excited for & proud of Kevin! 🤗 Next step - postdoc ⁦@StanfordCVI⁩

[John Giudicessi MD, PhD @JohnGiudicessi]

Strong work by @XGaoKevin presenting on how BrS, LQT3 and MEPPC-causative variants have distinct 3D clustering patterns @ #HRS2023! Potential new tool in the battle to interpret SCN5A VUS?

[Michael J. Ackerman MD,PhD @MJAckermanMDPhD]

⁦@XGaoKevin⁩ made ⁦@MayoClinic⁩ ⁦@MayoGradSchool⁩ & my team look very good here ⁦@HRSonline⁩ #HRS2023 w/ his talk on the 3-D structural analysis of the sodium channel & its ability to help distinguish “noise” from true #disease causing #genetic variants.

[Michael J. Ackerman MD,PhD @MJAckermanMDPhD]

Thanks @hrs_journal & congrats to my @MayoGradSchool PhD student @XGaoKevin on his characterization of a lidocaine/mexiletine-insensitive LQT3-causative mutation. Unfortunately, we were unable to become smart enough soon enough for the beautiful girl who owned this variant.

[Kevin Gao @XGaoKevin]

Also big shout out to @marissastutzman @DaveTester77 @JohnGiudicessi and others not on twitter. This is truly a team effort!

[Kevin Gao @XGaoKevin]

Excited to share our latest work in @hrs_journal on characterization of a novel SCN5A variant causing LQT3. Phenytoin could be effective as a variant specific therapy. Thanks @MJAckermanMDPhD for the mentorship!

[HeartRhythm @hrs_journal]

Functional Characterization and Identification of a Therapeutic for a Novel SCN5A-F1760C Variant Causing Type 3 Long QT Syndrome Refractory to All Guideline-Directed Therapies, by @MJAckermanMDPhD and colleagues https://t.co/9OMbUf2gLX

[Kevin Gao @XGaoKevin]

@MJAckermanMDPhD @hrs_journal @MayoGradSchool Thank you Dr. Ackerman! Always grateful for the mentorship!

[Kevin Gao @XGaoKevin]

Very excited to share my work on iPSC-CM modeling for MEPPC at #AHA22 Grateful to have the opportunity to work under the mentorship of @MJAckermanMDPhD @JohnGiudicessi and the amazing team at @MayoClinicWSRGH

[Michael J. Ackerman MD,PhD @MJAckermanMDPhD]

Very fortunate to have @XGaoKevin on my team. Kevin is a PhD student @MayoGradSchool and just finished is first ever presentation @AHAMeetings. The model system that he has developed for Multifocal Ectopic Purkinje-Related PVCs is really cool. Great work Kevin.

[Michael J. Ackerman MD,PhD @MJAckermanMDPhD]

Very fortunate to have @XGaoKevin on my team. Kevin is a PhD student @MayoGradSchool and just finished is first ever presentation @AHAMeetings. The model system that he has developed for Multifocal Ectopic Purkinje-Related PVCs is really cool. Great work Kevin.

[Kevin Gao @XGaoKevin]

Our latest study on a novel functional variant outside SCN5A encoded Nav1.5 voltage-sensing domain causing multifocal ectopic Purkinje-related premature contractions (MEPPC) is now available on @HRS_CaseReports. @JohnGiudicessi @MJAckermanMDPhD
https://t.co/cJq8J7b59r

[Kevin Gao @XGaoKevin]

My first @AHAMeetings poster presentation on SCN5A-associated Multifocal Ectopic Purkinje-Related Premature Contractions (MEPPC) goes live! Thanks to the mentorship from @MJAckermanMDPhD @JohnGiudicessi

[Michael J. Ackerman MD,PhD @MJAckermanMDPhD]

My PhD student ⁦@XGaoKevin⁩ from ��@MayoClinic ⁦@MayoGradSchool⁩ presenting his poster now ⁦@AHAScience⁩ #AHA2021 virtual meeting. Cool work & neat thesis on a relatively new SCN5A-opathy. Way to go Kevin.

[Kevin Gao @XGaoKevin]

@MJAckermanMDPhD @Starbucks @MayoClinic @RandyMoss @espn Maybe it’s time to try @cafesteamMN at discovery square🤓

[Kevin Gao @XGaoKevin]

Passed my oral qualifying exam and finally a Ph.D candidate at @MayoGradSchool. Thank you @MJAckermanMDPhD for you mentorship!

[Michael J. Ackerman MD,PhD @MJAckermanMDPhD]

CONGRATS ⁦@XGaoKevin⁩ on his first poster presentation at #HRS2021 detailing effect of #mexiletine on 3 different #LQTS re-engineered #heart cell models from pts w/ LQT1, LQT2, & LQT3. This Rx is not for just LQT3 anymore. At bench & at bedside, remember it for tough LQT2.